BTW
MJN

Boston Trust Walden’s Mead Johnson Nutrition Company MJN Stock Holding History

Boston Trust Walden’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-34,808
Closed -$3.1M – 379
2017
Q1 		$3.1M Sell
34,808
-225
-0.6% -$18.5K 0.05% 240
2016
Q4 		$2.48M Buy
35,033
+9,425
+37% +$702K 0.04% 252
2016
Q3 		$2.02M Buy
25,608
+923
+4% +$78.7K 0.03% 266
2016
Q2 		$2.24M Buy
24,685
+18,455
+296% +$1.56M 0.04% 260
2016
Q1 		$529K Sell
6,230
-675
-10% -$50.2K 0.01% 311
2015
Q4 		$545K Sell
6,905
-567
-8% -$44.7K 0.01% 307
2015
Q3 		$526K Sell
7,472
-99
-1% -$8.14K 0.01% 316
2015
Q2 		$683K Sell
7,571
-450
-6% -$43.4K 0.01% 302
2015
Q1 		$806K Sell
8,021
-548
-6% -$55.3K 0.01% 293
2014
Q4 		$862K Sell
8,569
-150
-2% -$14.9K 0.01% 294
2014
Q3 		$839K Buy
8,719
+190
+2% +$18K 0.01% 292
2014
Q2 		$795K Hold
8,529
– – 0.01% 288
2014
Q1 		$709K Buy
8,529
+1,750
+26% +$142K 0.01% 273
2013
Q4 		$568K Buy
6,779
+3,750
+124% +$305K 0.01% 287
2013
Q3 		$225K Hold
3,029
– – ﹤0.01% 314
2013
Q2 		$240K Buy
+3,029
New +$243K ﹤0.01% 306

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Boston Trust Walden's MJN Position: Q2 2017 in Review

Boston Trust Walden sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 34,808 shares — an estimated $3.1M sold.

Boston Trust Walden first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $3.1M in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Boston Trust Walden reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Boston Trust Walden sold 34,808 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $3.1M.
  • Boston Trust Walden first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Boston Trust Walden's Mead Johnson Nutrition Company position peaked at $3.1M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Boston Trust Walden's 13F filing for Q2 2017, filed 19 Jul 2017.